Related Experiment Video
Updated: Jul 19, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
[Sporadic cerebral amyloidotic angiopathy]
L Cabrejo1, P Chassagne, J Doucet
1Département de Neurologie, CHU de Rouen. Luciecabrejo@hotmail.com
Insights
Cerebral amyloid angiopathy (CAA) is common in older adults and can cause brain hemorrhages. Early diagnosis using MRI in demented patients is crucial for preventing bleeding, especially during anticoagulation therapy.
Area of Science:
- Neuropathology
- Vascular Neurology
- Geriatrics
Context:
- Sporadic cerebral amyloid angiopathy (CAA) affects over 30% of individuals over 85.
- CAA is characterized by microangiopathy and associated with lobar, cortical, or cerebellar hemorrhages.
- Dementia, often preceding hemorrhage, is present in 25-40% of CAA cases.
Purpose:
- To review prevalence, risk factors, and diagnostic criteria for CAA-related intracranial hemorrhages.
- To discuss diagnostic strategies and preventive measures for CAA.
- To highlight the importance of identifying CAA in elderly patients with dementia and atrial fibrillation undergoing anticoagulation.
Summary:
- CAA diagnosis involves Boston criteria, with clinical signs including recurrent hemorrhages and dementia.
- Brain MRI can detect microbleeding, aiding in CAA diagnosis and hemorrhage risk assessment.
- Identifying CAA in elderly demented patients is vital for managing anticoagulation therapy and preventing bleeds.
Impact:
- This review aids clinicians in diagnosing and managing CAA, particularly in at-risk elderly populations.
- Understanding CAA prevalence and risk factors can inform preventive strategies.
- Identifying CAA in patients on anticoagulation can reduce intracranial hemorrhage risk.
Introduction:
Sporadic cerebral amyloid angiopathy (CAA) is a microangiopathy identified by neuropathological examination in more than 30 percent of patients over 85 years of age.
State Of Art:
Boston criteria for diagnosis of CAA--related hemorrhage are as follows: "definite CAA", "Probable CAA with supporting pathology", "Probable CAA" and "Possible CAA". Clinical manifestations of CAA are either lobar, cortical, corticosubcortical or cerebellar hemorrhages associated with progressive dementia. Dementia, corresponding either to Alzheimer disease, vascular or mixed dementia, precedes hemorrhages in 25 to 40 percent of cases. Brain MRI can demonstrate microbleeding.
Perspectives:
This review compares data regarding CAA prevalence, intracranial hemorrhages, and their risk factors in old patients. Diagnosis and preventive strategies are discussed. It would be useful to identify those affected by CAA among elderly demented patients with atrial fibrillation requiring anticoagulation therapy.
Conclusions:
CAA is suspected in the presence of recurrent lobar or cerebellar hemorrhages, and moreover if associated with pre-existing dementia. In elderly demented patients, MRI criteria to detect CAA should be considered in order to prevent hemorrhage risk, particularly after anticoagulation therapy.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cerebral Edema ll: Pathophysiology
Dementia l: Introduction
Hemorrhagic Stroke l: Introduction
Alzheimer Disease l: Introduction
